Back to search
Sweat Gland Diseases
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Sweat Gland Diseases trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Sweat Gland Diseases trials you may qualify forThe main purpose of this study is to assess the efficacy of multiple dosing regimens of LAD191 compared to placebo in participants with moderate-to-severe Hidra…
Rollover study for participants from predetermined, Incyte-sponsored parent clinical trials of povorcitinib.
The purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidradeni…
This is a multinational, randomized, double-blind, placebo-controlled, Phase 2, dose finding study to evaluate the efficacy and safety of different doses of SAR…
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease p…
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
The purpose of the study is to evaluate the safety of long-term therapy of bimekizumab in study participants with moderate to severe hidradenitis suppurativa (H…
This is a study to evaluate the long-term safety, tolerability, and efficacy of sonelokimab in participants with moderate to severe hidradenitis suppurativa who…